Dramatically advance your ability to accurately diagnose brain disorders such as Alzheimer’s disease, epilepsy, and traumatic brain injury. Breakthrough quantitative volumetric imaging software solutions from CorTechs Labs are disrupting the tedious, manual process of imaging analysis with automated tools that achieve industry-leading levels of accuracy and speed.
“Mild involutional changes” and “age-appropriate atrophy” are no longer acceptable statements for the radiological report in the new age of quantitative radiology. NeuroQuant®, CorTechs Labs’ flagship quantitative MRI software product, provides more than the requisite ruling out of structural lesions. This sophisticated automated tool delivers accurate quantification that generates objective support for or against neurodegeneration in the setting of cognitive complaint. LesionQuant™, the automated lesion quantification module of NeuroQuant, combines T2 FLAIR and 3D T1 MRI analysis to provide clinicians with FLAIR lesion and subcortical brain structure quantification, as well as lesion and lesion change visualization. Finally, PETQuant™ enables clinical researchers to quantify subregional tracer binding in native patient brain space from PET brain studies.
Assess neurodegeneration in patients due to Alzheimer’s, frontotemporal dementia, corticobasal ganglionic disease, epilepsy, multiple sclerosis, traumatic brain injury, and more.
Color-coded segmented brain structures clearly delineate coronal, sagittal, and axial images.
Validate findings that aid in the diagnosis of a variety of brain disorders, using objective, quantifiable information.
Create full spreadsheets of your entire research study’s volumetric data with the press of a button.
Improve registration to CT in surgical and radiosurgical planning with images that are corrected for Radonc and Nsurg.
A key component of NeuroQuant is the normative database, which provides NeuroQuant the capability to compare an individual’s brain structure volume measurements to a healthy population. This allows NeuroQuant to deliver a precise indication of where that individual’s brain structure volume lies within an age- and gender-based reference chart, which aids physicians in their assessment of neurodegenerative conditions. This paper provides information on how CorTechs Labs’ normative database was created for NeuroQuant.